Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk! [PDF]
Medicina, 2023 Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice.
Rita Carlotta Santoro +3 more
doaj +3 more sources
Effect of carbamazepine and levetiracetam on coagulation parameters: Prothrombin time, activated partial thromboplastin time, D-dimer, and fibrinogen levels [PDF]
Journal of Medical BiochemistryBackground: Epilepsy is a prevalent neurological disorder, and evaluating its treatment strategies is highly significant. This study aimed to compare the effects of monotherapy with carbamazepine and levetiracetam on the results of coagulation tests ...
Li Jiaohui, Zhong Chengyun, Bian Guanji
doaj +3 more sources
Performance Evaluation of Four Activated Partial Thromboplastin Time Reagents [PDF]
Pharmacology and Clinical Pharmacy Research, 2018 Activated Partial Thromboplastin Time (APTT) is a hematological examination to identify hemostatic abnormalities. This study aimed to compare the performance evaluation of four APTT reagents, i.e., CK Prest, Pathromtin SL, Actin SL, and Cephascreen.
Peppi Z. Yuzaqi +2 more
doaj +2 more sources
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [PDF]
Journal of Multidisciplinary HealthcareFanchun Yang, Qingying Wang, Rui Ma, Fangzhen Deng, Jie Liu Department of Obstetrics and Gynecology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence: Jie Liu, Department of ...
Yang F, Wang Q, Ma R, Deng F, Liu J
doaj +2 more sources
Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study [PDF]
Diagnostics, 2023 (1) Background: The activated partial thromboplastin time (APTT)- based clot waveform analysis (CWA) quantitatively extends information obtained from the APTT waveform through its derivatives.
Wan Hui Wong +8 more
doaj +2 more sources
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [Letter] [PDF]
Journal of Multidisciplinary HealthcareZainarda,1,2,* Hasta Handayani Idrus3,* 1Faculty of Medicine, Hasanuddin University, Makassar, Indoensia; 2Department of Orthopedic, Dody Sarjoto Hospital, Makassar, Indoensia; 3Biomedical Research Center, Research Organization for Health ...
Zainarda, Idrus HH
doaj +2 more sources
Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients. [PDF]
PLoS ONE, 2022 BackgroundCOVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation.
Esayas Tekle +8 more
doaj +2 more sources
Activated Partial Thromboplastin Time Clot Waveform Analysis In Hemophilia A
Journal of Taibah University Medical Sciences, 2023 Maha Said +6 more
doaj +2 more sources
Activated Partial Thromboplastin Time Abnormality in Patients with Cholangiocarcinoma [PDF]
Clinical and Applied Thrombosis/Hemostasis, 2004 Cholangiocarcinoma can be detected worldwide, but is most common in tropical areas where crowded living conditions and poor sanitation exist. This infection can demonstrate a wide spectrum of clinical presentations from no complaints to arrest. Similar to the other liver diseases, the activated partial thromboplastin time abnormality can be seen in ...
Viroj Wiwanitkit
openaire +3 more sources
Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study [PDF]
Kidney MedLucy S. Wang +9 more
openalex +2 more sources